Patent · US Expired

Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase

US7550295B2 · kind B2 · utility

2Cited by
9References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 3, 2006
Grant dateJun 23, 2009
Priority date
Expiry dateMar 3, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24122
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides a modified vaccinia topoisomerase enzyme containing an affinity tag which is capable of facilitating purification of protein-DNA complexes away from unbound DNA. This invention further provides a modified sequence specific topoisomerase enzyme.This invention provides a method of ligating duplex DNAs, a method of molecular cloning of DNA, a method of synthesizing polynucleotides, and a method of gene targeting.Lastly, this invention provides a recombinant DNA molecule composed of segments of DNA which have been joined ex vivo by the use of a sequence specific topoisomerase and which has the capacity to transform a suitable host cell comprising a DNA sequence encoding polypeptide activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.